CPC 601
Latest Information Update: 17 Apr 2001
At a glance
- Originator Questcor Pharmaceuticals
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Reperfusion injury
Most Recent Events
- 17 Apr 2001 Discontinued-Preclinical for Reperfusion injury in USA (Unknown route)
- 31 Dec 1998 No-Development-Reported for Reperfusion injury in USA (Unknown route)
- 03 May 1996 Preclinical development for Reperfusion injury in USA (Unknown route)